Related Articles
Elsevier’s Oncology Journal Network Highlights | Elsevier
Welcome to our Elsevier’s Oncology Journal Network Highlights page
ScienceDirect
It has become increasingly clear in recent years that the international paediatric oncology community needs to develop ad hoc strategies to face the challenge of…
ScienceDirect
Read the latest articles of Current Problems in Cancer at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
ScienceDirect
Read the latest articles of Translational Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Elsevier’s Oncology Journal Network Highlights | Elsevier
Welcome to our Elsevier’s Oncology Journal Network Highlights page
The Breast
x De-escalation of loco-regional treatment in breast cancer: Time to find the balance? Edited by Oreste Gentilini, Philip Poortmans, Maria João Cardoso, Elzbieta Senkus-Konefka Breast…
Half century of cancer research: In honor of Dr.rer.nat Manfred Schwab, the former Editor-in-Chief of Cancer Letters
Available online 9 February 2024, 216722 There are more references available in the full text version of this
Immunotherapy use in older adults with cancer with frailty: A young SIOG review paper
Immune checkpoint inhibitors (ICIs) became a treatment option in most tumor types and improved survival in patients with cancer in the last decade. Older patients…
Immunotherapy use in older adults with cancer with frailty: A young SIOG review paper
Immune checkpoint inhibitors (ICIs) became a treatment option in most tumor types and improved survival in patients with cancer in the last decade. Older patients…
Survival outcomes in older adults undergoing early phase clinical trials
Older patients are often excluded from clinical trials with the majority of patients being between the ages of 18 and 64 [1]. This may be…